Vivos Therapeutics, Inc. (VVOS) Dividend History

Vivos Therapeutics, Inc. (VVOS) is a healthcare company focused on the diagnosis and treatment of sleep and airway-related disorders. It specializes in non-invasive, outpatient treatments for conditions such as sleep apnea through its proprietary Vivos System, which combines custom oral appliances with advanced digital technology. The company aims to provide minimally invasive solutions to improve patient outcomes related to sleep health and airway function.

7921 Southpark Plaza,, Littleton, CO, 80120
Phone: (866)908-4867
Website: https://www.vivos.com

Dividend History

Vivos Therapeutics, Inc. currently does not pay dividends

Company News

  • 8 Out of 10 Newly Diagnosed OSA Patients Choose Oral Appliance Therapy Over CPAP and Preferred Vivos’ Flagship CARE Oral Medical Devices 5 to 1 Over Traditional Oral Appliances 8 Out of 10 Newly Diagnosed OSA Patients Choose Oral Appliance Therapy Over CPAP and Preferred Vivos’ Flagship CARE Oral Medical Devices 5 to 1 Over Traditional Oral Appliances

    GlobeNewswire Inc.
  • Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash. Doma Holdings shares jumped 34.1% to $6.09 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Vast Renewables Limited (NASDAQ: VSTE) rose 213.9% to $9.70 in pre-market trading after jumping 39% on Thursday. MediaCo Holding Inc. (NASDAQ: MDIA) gained 84% to $0.9601 in pre-market trading after dipping more than 17% on Thursday. Galera Therapeutics, Inc. (NASDAQ: GRTX) gained 49.5% to $0.2093 in pre-market trading. Galera Therapeutics posted fourth-quarter results on Thursday. Qilian International Holding Group Limited (NASDAQ: QLI) shares gained 32.2% to $0.8399 in pre-market trading. Sunshine Biopharma, Inc. (NASDAQ: SBFM) gained 30.7% to $0.0791 in pre-market trading after the company reported operating results for the fiscal year ended Dec. 31, 2023. Xilio Therapeutics, Inc. (NASDAQ: XLO) shares rose 26.8% to $1.37 in pre-market ...

    Benzinga
  • Vivos Therapeutics jumped more than 270% after the FDA cleared the company's devices for severe sleep apnea.

    MarketWatch
    Featured Companies: PHG
  • If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Vivos Therapeutics, Inc. (VVOS) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

    Zacks Investment Research
  • Here's how to create a profitable penny stocks watchlist The post Creating a Profitable Penny Stocks Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: BCLI
Page data last updated 07/24/2025 00:56:09 UTC